These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8276184)

  • 1. Pathogenic factors in early recurrence of cholesterol gallstones.
    Berr F; Mayer M; Sackmann MF; Sauerbruch T; Holl J; Paumgartner G
    Gastroenterology; 1994 Jan; 106(1):215-24. PubMed ID: 8276184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
    Gustafsson U; Sahlin S; Einarsson C
    Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disorders of bile acid metabolism in cholesterol gallstone disease.
    Berr F; Pratschke E; Fischer S; Paumgartner G
    J Clin Invest; 1992 Sep; 90(3):859-68. PubMed ID: 1522238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
    Jüngst D; Brenner G; Pratschke E; Paumgartner G
    J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit.
    Shoda J; He BF; Tanaka N; Matsuzaki Y; Osuga T; Yamamori S; Miyazaki H; Sjövall J
    Hepatology; 1995 May; 21(5):1291-302. PubMed ID: 7737634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of gallbladder emptying decreases cholesterol saturation in bile in the Richardson ground squirrel.
    Pauletzki JG; Xu QW; Shaffer EA
    Hepatology; 1995 Jul; 22(1):325-31. PubMed ID: 7601426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired gallbladder mucosal function in aged gallstone patients suppresses gallstone recurrence after successful extracorporeal shockwave lithotripsy.
    Tazuma S; Nishioka T; Ochi H; Hyogo H; Sunami Y; Nakai K; Tsuboi K; Asamoto Y; Sakomoto M; Numata Y; Kanno K; Yamaguchi A; Kobuke T; Komichi D; Nonaka Y; Chayama K
    J Gastroenterol Hepatol; 2003 Feb; 18(2):157-61. PubMed ID: 12542599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: pathogenesis of gallstones.
    Dowling RH
    Aliment Pharmacol Ther; 2000 May; 14 Suppl 2():39-47. PubMed ID: 10903002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence.
    Pauletzki J; Althaus R; Holl J; Sackmann M; Paumgartner G
    Gastroenterology; 1996 Sep; 111(3):765-71. PubMed ID: 8780583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients.
    LaRusso NF; Hoffman NE; Hofmann AF; Northfield TC; Thistle JL
    Gastroenterology; 1975 Dec; 69(6):1301-14. PubMed ID: 1193329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy.
    Sharma BC; Agarwal DK; Dhiman RK; Baijal SS; Choudhuri G; Saraswat VA
    Gastroenterology; 1998 Jul; 115(1):124-8. PubMed ID: 9649467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy.
    Portincasa P; van Erpecum KJ; van De Meeberg PC; Dallinga-Thie GM; de Bruin TW; van Berge-Henegouwen GP
    Hepatology; 1996 Sep; 24(3):580-7. PubMed ID: 8781328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients.
    Nilsell K; Angelin B; Liljeqvist L; Einarsson K
    Gastroenterology; 1985 Aug; 89(2):287-93. PubMed ID: 4007420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease.
    Yago MD; González V; Serrano P; Calpena R; Martínez MA; Martínez-Victoria E; Mañas M
    Nutrition; 2005 Mar; 21(3):339-47. PubMed ID: 15797676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
    Wang HH; Portincasa P; Wang DQ
    Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
    Northfield TC; Hofmann AF
    Gut; 1975 Jan; 16(1):1-11. PubMed ID: 806491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallbladder emptying in vivo, bile composition, and nucleation of cholesterol crystals in patients with cholesterol gallstones.
    Stolk MF; van Erpecum KJ; Renooij W; Portincasa P; van de Heijning BJ; vanBerge-Henegouwen GP
    Gastroenterology; 1995 Jun; 108(6):1882-8. PubMed ID: 7768394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids.
    Kern F; Everson GT; DeMark B; McKinley C; Showalter R; Braverman DZ; Szczepanik-Van Leeuwen P; Klein PD
    J Lab Clin Med; 1982 Jun; 99(6):798-805. PubMed ID: 7077124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of gallstones.
    Carey MC
    Recenti Prog Med; 1992; 83(7-8):379-91. PubMed ID: 1529152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary N-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease.
    Berr F; Holl J; Jüngst D; Fischer S; Richter WO; Seifferth B; Paumgartner G
    Hepatology; 1992 Oct; 16(4):960-7. PubMed ID: 1398503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.